MDxHealth SA (MDXH) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $0.21, -65.79% vs the prior close of $0.60.
- Volume 16.89M shares, 2.3x its 50-day average (heavy).
- New SEC filings: 6-K (Oct 16, 2026), SCHEDULE 13D/A (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
MDXH slides 65.8% to $0.21, a 52-week low on 2.3x normal volume. Closed at $0.21, -65.79% vs the prior close of $0.60. Day range $0.19β$0.41, opened at $0.40.
MDXH daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 β MDXH slides 65.8% to $0.21, a 52-week low on 2.3x normal volume
- Closed at $0.21, -65.79% vs the prior close of $0.60. Day range $0.19β$0.41, opened at $0.40.
- Volume was 16.89M shares, 2.3x its 50-day average of 7.22M β unusually heavy trading.
- Price is -67.6% vs its 50-day average ($0.64) and -87.7% vs its 200-day average ($1.69).
- 52-week range $0.19β$5.33; today's close sits at 0% of that range, 96.1% below the 52-week high.
- That makes 3 straight losses.
Oct 15, 2026 β MDXH slides 4.4% to $0.60
- Closed at $0.60, -4.43% vs the prior close of $0.63. Day range $0.58β$0.65, opened at $0.64.
- Volume was 782.70K shares, 0.1x its 50-day average of 7.20M β lighter than usual.
- Price is -5.9% vs its 50-day average ($0.64) and -64.5% vs its 200-day average ($1.70).
- 52-week range $0.40β$5.33; today's close sits at 4% of that range, 88.7% below the 52-week high.
Oct 14, 2026 β MDXH slides 4.2% to $0.63
- Closed at $0.63, -4.24% vs the prior close of $0.66. Day range $0.63β$0.68, opened at $0.67.
- Volume was 211.60K shares, 0.0x its 50-day average of 7.20M β lighter than usual.
- Price is -1.0% vs its 50-day average ($0.64) and -63.2% vs its 200-day average ($1.72).
- 52-week range $0.40β$5.33; today's close sits at 5% of that range, 88.1% below the 52-week high.
Oct 13, 2026 β MDXH jumps 9.3% to $0.66, 3 up days in a row
- Closed at $0.66, +9.27% vs the prior close of $0.60. Day range $0.60β$0.67, opened at $0.60.
- Volume was 488.50K shares, 0.1x its 50-day average of 7.20M β lighter than usual.
- Price is +4.0% vs its 50-day average ($0.63) and -61.9% vs its 200-day average ($1.73).
- 52-week range $0.40β$5.33; today's close sits at 5% of that range, 87.6% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 β MDXH rises 2.4% to $0.60
- Closed at $0.60, +2.37% vs the prior close of $0.59. Day range $0.58β$0.61, opened at $0.58.
- Volume was 294.00K shares, 0.0x its 50-day average of 7.20M β lighter than usual.
- Price is -4.2% vs its 50-day average ($0.63) and -65.4% vs its 200-day average ($1.74).
- 52-week range $0.40β$5.33; today's close sits at 4% of that range, 88.7% below the 52-week high.
Oct 9, 2026 β MDXH rises 1.5% to $0.59
- Closed at $0.59, +1.55% vs the prior close of $0.58. Day range $0.57β$0.60, opened at $0.57.
- Volume was 48.10K shares, 0.0x its 50-day average of 7.20M β lighter than usual.
- Price is -5.9% vs its 50-day average ($0.63) and -66.5% vs its 200-day average ($1.76).
- 52-week range $0.40β$5.33; today's close sits at 4% of that range, 88.9% below the 52-week high.
Oct 8, 2026 β MDXH slides 3.2% to $0.58
- Closed at $0.58, -3.17% vs the prior close of $0.60. Day range $0.57β$0.61, opened at $0.60.
- Volume was 59.20K shares, 0.0x its 50-day average of 7.20M β lighter than usual.
- Price is -6.8% vs its 50-day average ($0.62) and -67.2% vs its 200-day average ($1.77).
- 52-week range $0.40β$5.33; today's close sits at 4% of that range, 89.1% below the 52-week high.
Oct 7, 2026 β MDXH ends flat (+0.0%) to $0.60
- Closed at $0.60, +0.00% vs the prior close of $0.60. Day range $0.59β$0.61, opened at $0.59.
- Volume was 332.90K shares, 0.0x its 50-day average of 7.20M β lighter than usual.
- Price is -3.1% vs its 50-day average ($0.62) and -66.4% vs its 200-day average ($1.79).
- 52-week range $0.40β$5.33; today's close sits at 4% of that range, 88.7% below the 52-week high.
Oct 6, 2026 β MDXH rises 0.5% to $0.60
- Closed at $0.60, +0.50% vs the prior close of $0.60. Day range $0.59β$0.61, opened at $0.61.
- Volume was 184.40K shares, 0.0x its 50-day average of 7.19M β lighter than usual.
- Price is -2.5% vs its 50-day average ($0.62) and -66.6% vs its 200-day average ($1.80).
- 52-week range $0.40β$5.33; today's close sits at 4% of that range, 88.7% below the 52-week high.
Oct 5, 2026 β MDXH jumps 4.6% to $0.60
- Closed at $0.60, +4.55% vs the prior close of $0.57. Day range $0.56β$0.61, opened at $0.57.
- Volume was 126.20K shares, 0.0x its 50-day average of 7.20M β lighter than usual.
- Price is -2.5% vs its 50-day average ($0.61) and -67.0% vs its 200-day average ($1.81).
- 52-week range $0.40β$5.33; today's close sits at 4% of that range, 88.8% below the 52-week high.
Oct 2, 2026 β MDXH dips 0.9% to $0.57
- Closed at $0.57, -0.87% vs the prior close of $0.58. Day range $0.56β$0.60, opened at $0.57.
- Volume was 78.10K shares, 0.0x its 50-day average of 7.20M β lighter than usual.
- Price is -6.1% vs its 50-day average ($0.61) and -68.7% vs its 200-day average ($1.82).
- 52-week range $0.40β$5.33; today's close sits at 3% of that range, 89.3% below the 52-week high.
MDXH latest news & SEC filings
Every SEC filing by or about MDXH in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Oct 15, 2026 Β· Form SCHEDULE 13D/A β Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Sep 17, 2026 Β· Form 144 β Planned insider sale
Notice of proposed sale (Form 144) β an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Sep 3, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 17, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 17, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
- Bednarski Eric bought 2,202,643 shares at $0.45 (β$991.19K) on Aug 13, 2026
- Bednarski Eric bought 2,202,643 shares at $0.45 (β$991.19K) on Aug 13, 2026
- Mvm Partners, Llc bought 2,202,643 shares at $0.45 (β$991.19K) on Aug 13, 2026
- Mvm Partners, Llc bought 2,202,643 shares at $0.45 (β$991.19K) on Aug 13, 2026
- Bednarski Eric bought 2,202,643 shares at $0.45 (β$991.19K) on Aug 13, 2026
- Bednarski Eric bought 2,202,643 shares at $0.45 (β$991.19K) on Aug 13, 2026
- β¦plus 2 more transaction lines in the filing.
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 14, 2026 Β· Form SCHEDULE 13D β Activist-style stake (13D)
Activist-style stake (13D) β an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 13, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 13, 2026 Β· Form 424B5 β Prospectus supplement
Prospectus supplement β the company is selling securities off a shelf registration
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 13, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Aug 13, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 24, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Jul 8, 2026 Β· Form SCHEDULE 13G/A β Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 2, 2026 Β· Form 6-K β Report from a foreign company (6-K)
Report from a foreign company (6-K) β news it published at home
Things to know before you trade MDXH
- How much it moves: over the last 20 sessions the average daily move was 6.58% (largest 65.8%). That is a volatile stock.
- Liquidity: about 1.08M shares (β$224.10K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $0.21 vs a range of $0.19β$5.33 (0% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 8 open-market buys, 0 sales; latest: Eric Bednarski bought 2,202,643 shares on Aug 13, 2026.
- Latest filings: 6-K Oct 16, 2026; 6-K Sep 3, 2026; 6-K Aug 13, 2026.
- Listing: Nasdaq Β· industry: Services-Medical Laboratories.
MDXH market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 0.40 | 0.41 | 0.19 | 0.21 | 16.89M |
| Oct 15, 2026 | 0.64 | 0.65 | 0.58 | 0.60 | 782.70K |
| Oct 14, 2026 | 0.67 | 0.68 | 0.63 | 0.63 | 211.60K |
| Oct 13, 2026 | 0.60 | 0.67 | 0.60 | 0.66 | 488.50K |
| Oct 12, 2026 | 0.58 | 0.61 | 0.58 | 0.60 | 294.00K |
| Oct 9, 2026 | 0.57 | 0.60 | 0.57 | 0.59 | 48.10K |
| Oct 8, 2026 | 0.60 | 0.61 | 0.57 | 0.58 | 59.20K |
| Oct 7, 2026 | 0.59 | 0.61 | 0.59 | 0.60 | 332.90K |
| Oct 6, 2026 | 0.61 | 0.61 | 0.59 | 0.60 | 184.40K |
| Oct 5, 2026 | 0.57 | 0.61 | 0.56 | 0.60 | 126.20K |
| Oct 2, 2026 | 0.57 | 0.60 | 0.56 | 0.57 | 78.10K |
| Oct 1, 2026 | 0.60 | 0.60 | 0.56 | 0.58 | 117.80K |
| Sep 30, 2026 | 0.52 | 0.64 | 0.52 | 0.58 | 451.20K |
| Sep 29, 2026 | 0.53 | 0.55 | 0.52 | 0.52 | 311.00K |
| Sep 28, 2026 | 0.56 | 0.57 | 0.55 | 0.55 | 94.70K |
| Sep 25, 2026 | 0.58 | 0.60 | 0.56 | 0.56 | 235.10K |
| Sep 24, 2026 | 0.61 | 0.61 | 0.56 | 0.58 | 222.70K |
| Sep 23, 2026 | 0.60 | 0.62 | 0.58 | 0.61 | 106.50K |
| Sep 22, 2026 | 0.64 | 0.64 | 0.59 | 0.60 | 314.20K |
| Sep 21, 2026 | 0.63 | 0.65 | 0.60 | 0.60 | 347.70K |
About MDxHealth SA
MDxHealth SA (MDXH) is listed on the Nasdaq and classified by the SEC under βServices-Medical Laboratoriesβ. Its business address is in HERSTAL, Belgium. State of incorporation: Belgium. Fiscal year ends β. SEC CIK 1872529.
MDXH board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Eric Bednarski | Director | Aug 17, 2026 |
| Don M Hardison | Director | Jun 3, 2026 |
| Koen Hoffman | Director | Jun 3, 2026 |
| Michael Holder | Director | Jun 3, 2026 |
| Partners, Llc Mvm | Director | Aug 17, 2026 |
| Michael Mcgarrity | Chief Executive Officer | Jun 3, 2026 |
| Sanford Jay Siegel | Director | Jun 3, 2026 |
| Hilde Windels | Director | Jun 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| John Bellano | Chief Commercial Officer | Jun 3, 2026 |
| Ron Kalfus | Chief Financial Officer | Apr 13, 2026 |
| Michael Mcgarrity | Chief Executive Officer | Jun 3, 2026 |
| Brendan Oconnell | VP, Finance and Accounting | Jun 3, 2026 |
| Joseph Sollee | See Remarks | Jun 3, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Aug 13, 2026 | Eric Bednarski | Buy | 2,202,643 | $0.45 |
| Aug 13, 2026 | Eric Bednarski | Buy | 2,202,643 | $0.45 |
| Aug 13, 2026 | Partners, Llc Mvm | Buy | 2,202,643 | $0.45 |
| Aug 13, 2026 | Partners, Llc Mvm | Buy | 2,202,643 | $0.45 |
| Aug 13, 2026 | Eric Bednarski | Buy | 2,202,643 | $0.45 |
| Aug 13, 2026 | Eric Bednarski | Buy | 2,202,643 | $0.45 |
| Aug 13, 2026 | Partners, Llc Mvm | Buy | 2,202,643 | $0.45 |
| Aug 13, 2026 | Partners, Llc Mvm | Buy | 2,202,643 | $0.45 |
MDXH financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| No annual XBRL figures available (foreign filers often report on Form 20-F). | ||||
Latest balance sheet: total assets $β, total liabilities $β, cash $β.
MDXH earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Services-Medical Laboratories
Natera (NTRA)Guardant Health (GH)Quest Diagnostics (DGX)Labcorp (LH)Grail (GRAL)Caris Life Sciences (CAI)Celcuity (CELC)CareDx (CDNA)Veracyte (VCYT)BillionToOne (BLLN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MDXH
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.